ASX
Starpharma Holdings Limited
SPL:ASX•Healthcare
Sensitive ASX Announcement
FDA Grants SPA Agreement for Phase 3 Recurrent BV Trial
Published: 14/07/14, 10:10am (AEST)•3 pages